Mounjaro is administered as a once-weekly subcutaneous injection, with treatment starting at 2.5 mg for 4 weeks as an initiation dose (not intended for glycaemic control)
GLP-1 and GIP With regard to metabolic effects, the best characterized DPP-4 substrates are the two incretin hormones, GLP-1, and glucose-dependent insulinotropic polypeptide (GIP)
When Is the Best Time to Get Botox While on Mounjaro
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight reduction for those struggling with obesity
However, the clinical symptoms of psoriasis may vary and depend on its type
If a Wegovy pen is not working properly, discard it without using it